Microbiological Testing/Measurement TRIZ Cases

Microfluidic compartments co-encapsulate cells with barcoded oligonucleotides to capture transcriptomic changes during ligand exposure.

Graphene field-effect transistor detects pH shifts from acetylcholinesterase reactions to identify gas inhibitors with high sensitivity.

Affinity chromatography enriches specific oxidative modifications to resolve measurement precision limits in complex biological mixtures.

A panel of twelve RNA markers predicts drug-resistant epilepsy risk in young tuberous sclerosis patients before seizure onset.

MIRA assay isolates methylated DNA using GST-MBD2b fusion protein binding, eliminating sodium bisulfite conversion labor while enhancing detection sensitivity.

Platelet biomarkers detect chromatin-bound MDM2 cancers early, resolving diagnostic complexity.

Tamoxifen induction of Axin1 expression in transgenic mice establishes a combined disease model for systematic pathogenesis study and drug screening.

Antibody-bound solid support isolates telomerase to reduce background noise from cell extract impurities during sensitive activity detection.

Cysteine residues form intersubunit disulfide bonds in a mutant glucose dehydrogenase, preventing activity loss at elevated temperatures.

Room temperature stabilization of nucleic acid sequences eliminates cold chain requirements while maintaining RNA integrity for reliable microbial detection.

Reversibly inactivated nuclease prevents contamination by digesting products post-reaction.

Triploid bush watermelon plants resolve yield constraints by using a recessive bush allele to enable higher planting density without reducing fruit quality.

Segmentation and intermediary algorithms process complex mutation patterns to determine tipranavir susceptibility, resolving interpretation difficulty.

Segmented PTEN and SDH analysis improves diagnostic completeness while managing workflow complexity.

Whole transcriptome sequencing identifies high HGF and c-Met expression levels to guide targeted cancer therapy.

Low-pass genome sequencing detects absence of heterozygosity by aligning reads and calculating homozygous single-nucleotide variant rates across sliding windows.

Segmented breeding generations resolve contradictions between rapid maturity and high yield uniformity by applying preliminary selection for stress resistance.

Restriction enzymes digest non-target nucleic acids to enrich rare mutations, resolving sensitivity limits in wild-type majority samples.

Dual capturing substances bind secreted molecules to single cells for precise analysis.

Leukocyte reduction filters and magnetic separation isolate fetal nucleated red blood cells from maternal blood samples.

Antibodies targeting phosphorylated DICER1 inhibit tumor progression in cancers lacking effective therapies.

Molecular markers identify functional restorer genes in wheat plants for hybrid seed production.

Proximity ligation preserves spatial-proximal and molecular contiguity in nucleic acid templates, resolving fragmentation-induced information loss.

Constant-temperature LAMP assays using specific primers detect M. pneumoniae nucleic acids, eliminating thermal cyclers and reducing diagnostic delays.

Targeted sequencing of the HBV polymerase gene resolves detection inaccuracies by identifying specific drug resistance mutations.

A disposable biosensor test strip uses alcohol dehydrogenase to detect ethanol in blood samples via amperometric current.

ECAD and SPINK1 biomarkers replace invasive pressure measurements, reducing patient risk while maintaining diagnostic precision.

Short oligonucleotide primers target the mitochondrial 12S gene to enable species identification in degraded environmental samples.

A qPCR-based method quantifies isolated DNA using a quality-mass constant to determine sequencing readiness.

A nucleic acid sequencing device applies a variable electrical field to measure strand lengths through resonance conditions.

A nanopore current measurement circuit uses a delay unit and resistance feedback to generate target pulse signals for accurate sensor data processing.

A conjugate preparation method blocks amino groups on enzyme surfaces before carbodiimide activation to form stable cross-links.

Measuring decorin gene expression levels predicts sensitivity to the anticancer drug S-1, avoiding complex cell culture techniques.

A copper-free interconnect device uses conductive paste contacts to establish electrical connections without micro-vias.

Analyzing specific microRNA and RNase signatures in stored red blood cells to monitor quality.

A radical initiator converts modified cytosine residues to detectable forms, eliminating hazardous borane reagents and reducing sample loss during detection.

Identifying inactivating mutations in CIC and FUBP1 genes enables precise detection of oligodendrogliomas.

CRISPR/Cas12a trans cleavage detects specific pathogen nucleic acid fragments, resolving detection time and contamination risks in clinical samples.

A genetic cross-matching method compares recipient and donor genotypes to select compatible blood products.

A closed-tube RT-PCR reagent kit merges nucleic acid extraction and amplification into a single reaction vessel using tolerant enzymes.

Segmented genetic testing for CYP2C9 and HLA-B*1502 alleles identifies hypersensitivity risks, preventing Stevens-Johnson syndrome.

Multivalent cation salts selectively precipitate thiophosphoramidate-linked polynucleotides, reducing non-target contaminants by up to 95%.

Phage display technology replaces animal immunization to rapidly identify microbial redox enzymes, enabling sensitive electrochemical biosensors.

Circulating miR-718 levels diagnose ascending aorta dilation, replacing complex imaging equipment with simple biochemical assays.

Neph3 expression identifies pure pancreatic progenitor cells, resolving the trade-off between high purity and the introduction of exogenous proteins.

Placing a filter upstream of the fluidic resistor prevents particle clogging, ensuring stable fluidic resistance without blockage risks.

Extracellular matrix components aggregate blood cells to recover circulating tumor cells without damage, resolving white blood cell loss and process complexity.

NMR relaxometer determines coagulation time using T2 relaxation shifts, eliminating complex optical equipment and large blood volumes.